-
Product Insights
NewJuvenile Macular Degeneration (Stargardt Disease) – Drugs In Development, 2024
Empower your strategies with our Juvenile Macular Degeneration (Stargardt Disease) – Drugs In Development, 2024 report and make more profitable business decisions. Juvenile macular degeneration is a series of inherited eye disorders that affects children and young adults. The most common form of juvenile macular degeneration is Stargardt disease, an inherited autosomal recessive syndrome. Signs and symptoms include blurry or fuzzy vision; dark, empty spots in the center of vision; and difficulty reading or performing detail work. Risk factors include arteriosclerosis,...
-
Product Insights
NewRetinopathy Of Prematurity – Drugs In Development, 2024
Empower your strategies with our Retinopathy Of Prematurity – Drugs In Development, 2024 report and make more profitable business decisions. Retinopathy of prematurity (ROP) is a disease that affects immature vasculature in the eyes of premature babies. This disorder, which usually develops in both eyes, is one of the most common causes of visual loss in childhood and can lead to lifelong vision impairment and blindness. Risk factors for the development of ROP include prematurity, extremely low birth weight, and multiple...
-
Product Insights
NewBlepharitis – Drugs In Development, 2024
Empower your strategies with our Blepharitis – Drugs In Development, 2024 report and make more profitable business decisions. Blepharitis is an inflammation of the eyelids, usually caused by an excess growth of bacteria that is ordinarily found on the skin, blockage of the eyelid's oil glands, and occasionally allergies. Blepharitis signs and symptoms include red and watery eyes, itchy eyelids, and sensitivity to light. Treatment includes antibiotics, lubricating eye drops, and steroid eye drops or ointments. The Blepharitis drugs in development...
-
Product Insights
NewCorneal Dystrophy – Drugs In Development, 2024
Empower your strategies with our Corneal Dystrophy – Drugs In Development, 2024 report and make more profitable business decisions. Corneal dystrophy (CD) is defined as a collection of rare hereditary non-inflammatory disorders of abnormal deposition of substances in the cornea. The material may cause the cornea to lose its transparency and can cause loss of vision or blurred vision. Corneal dystrophies can appear at any age and men and women are equally affected by most corneal dystrophies. The symptoms of corneal...
-
Product Insights
NewLeber Congenital Amaurosis (LCA) – Drugs In Development, 2024
Empower your strategies with our Leber Congenital Amaurosis (LCA) – Drugs In Development, 2024 report and make more profitable business decisions. Leber congenital amaurosis (LCA) is a genetic eye disorder that primarily affects the retina, which is the specialized tissue at the back of the eye that detects light and color. This condition is the most common cause of inherited blindness in childhood. Symptoms include vision loss, roving eye movements, deep-set eyes, developmental delay, epilepsy, and motor skill impairment. The Leber...
-
Product Insights
NewLeber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) – Drugs In Development, 2024
Empower your strategies with our Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) – Drugs In Development, 2024 report and make more profitable business decisions. Leber’s hereditary optic neuropathy (LHON) is an inherited form of vision loss. This condition usually begins in a person's teens or twenties; rare cases may appear in early childhood or later in adulthood. Males are affected much more often than females. Symptoms include eye pain or discomfort, numbness, tingling, and clouding of vision. Predisposing factors include age,...
-
Product Insights
NewCataract – Drugs In Development, 2024
Empower your strategies with our Cataract – Drugs In Development, 2024 report and make more profitable business decisions. A cataract is a clouding of the normally clear lens of eye that affects vision. Symptoms include clouded, blurred, or dim vision; increasing difficulty with vision at night; fading or yellowing of colors; double vision in a single eye; and frequent prescription changes in eye wear. Risk factors include age, diabetes, excessive alcohol consumption, high blood pressure, obesity, and smoking. The Cataract drugs...
-
Product Insights
NewMacular Edema – Drugs In Development, 2024
Empower your strategies with our Macular Edema – Drugs In Development, 2024 report and make more profitable business decisions. Macular edema is swelling or fluid retention in a specialized part of the retina called the macula. Symptoms of macular edema include blurred or wavy central vision and/or colors appear changed. There are many causes of macular edema. It is frequently associated with diabetes, where damaged blood vessels in the retina begin to leak fluids, including small amounts of blood, into the...
-
Product Insights
NewMyopia – Drugs In Development, 2024
Empower your strategies with our Myopia – Drugs In Development, 2024 report and make more profitable business decisions. Myopia, a form of nearsightedness, is a ophthalmological disorder that results in blurred vision when looking at distant objects. This occurs due to the improper refraction of light in the eye, causing the focal point to fall in front of the retina, rather than on it. Close-up objects can still be seen clearly. The underlying cause of myopia can be attributed to specific...
-
Product Insights
NewAllergic Conjunctivitis – Drugs In Development, 2024
Empower your strategies with our Allergic Conjunctivitis – Drugs In Development, 2024 report and make more profitable business decisions. Allergic conjunctivitis occurs when the clear layer of tissue lining the eyelids and covering the white of the eye (conjunctiva) becomes swollen or inflamed due to a reaction to pollen, dander, mold, or other allergy-causing substances. Symptoms include intense itching, puffy eyelids, widened (dilated) vessels in the clear tissue covering the white of the eye, and stringy eye discharge. Treatment includes antihistamine...